Biology Reference
In-Depth Information
95. Gauduin MC, Safrit JT, Weir R,
et al
. (1995) Pre- and postexposure
protection against human immunodeficiency virus type 1 infection
mediated by a monoclonal antibody.
J Infect Dis
171
: 1203-1209.
96. Parren PW, Ditzel HJ, Gulizia RJ,
et al
. (1995) Protection against
HIV-1 infection in hu-PBL-SCID mice by passive immunization with
a neutralizing human monoclonal antibody against the gp120 CD4-
binding site.
AIDS
9
: F1-6.
97. Safrit JT, Fung MS, Andrews CA,
et al
. (1993) hu-PBL-SCID mice
can be protected from HIV-1 infection by passive transfer of mono-
clonal antibody to the principal neutralizing determinant of envelope
gp120.
AIDS
7
: 15-21.
98. Parren PW, Gauduin MC, Koup RA,
et al
. (1997) Erratum to
“Relevance of the antibody response against human immunodeficiency
virus type 1 envelope to vaccine design”.
Immunol Lett
58
: 125-132.
99. Parren PW, Gauduin MC, Koup RA,
et al
. (1997) Erratum to
“Relevance of the antibody response against human immunodeficiency
virus type 1 envelope to vaccine design”.
Immunol Lett
58
: 125-132.
100. Mosier DE. (1995) Distinct rate and patterns of human CD4
+
T-cell
depletion in hu-PBL-SCID mice infected with different isolates of the
human immunodeficiency virus.
J Clin Immunol
15
: 130S-133S.
101. Mascola JR, Lewis MG, Stiegler G,
et al
. (1999) Protection of
macaques against pathogenic simian/human immunodeficiency virus
89.6PD by passive transfer of neutralizing antibodies.
J Virol
73
:
4009-4018.
102. Mascola JR, Stiegler G, VanCott TC,
et al
. (2000) Protection of
macaques against vaginal transmission of a pathogenic HIV-1/SIV
chimeric virus by passive infusion of neutralizing antibodies.
Nature
Medicine
6
: 207-210.
103. Parren PW, Wang M, Trkola A,
et al
. (1998) Antibody neutralization-
resistant primary isolates of human immunodeficiency virus type 1.
J Virol
72
: 10270-10274.
104. Mascola JR, Lewis MG, Stiegler G,
et al
. (1999) Protection of
macaques against pathogenic simian/human immunodeficiency virus
89.6PD by passive transfer of neutralizing antibodies.
J Virol
73
:
4009-4018.
105. Nishimura Y, Igarashi T, Haigwood NL,
et al
. (2003) Transfer of neu-
tralizing IgG to macaques 6 h but not 24 h after SHIV infection con-
fers sterilizing protection: implications for HIV-1 vaccine development.
Proc Natl Acad Sci USA
100
: 15131-15136 Epub 2003 Nov 19.
